CoChat

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases

Open access
Takeuchi, Toshihide, Nagai, Yoshitaka · 2017 · Brain Sciences

The DOI matches its Crossref record; 147 of the 149 references it cites were found in a registry or an index.

Abstract

The polyglutamine (polyQ) diseases, such as Huntington’s disease and several types of spinocerebellar ataxias, are a group of inherited neurodegenerative diseases that are caused by an abnormal expansion of the polyQ tract in disease-causative proteins. Proteins with an abnormally expanded polyQ stretch undergo a conformational transition to β-sheet rich structure, which assemble into insoluble aggregates with β-sheet rich amyloid fibrillar structures and accumulate as inclusion bodies in neurons, eventually leading to neurodegeneration. Since misfolding and aggregation of the expanded polyQ proteins are the most upstream event in the most common pathogenic cascade of the polyQ diseases, they are proposed to be one of the most ideal targets for development of disease-modifying therapies for polyQ diseases. In this review, we summarize the current understanding of the molecular pathogenic mechanisms of the polyQ diseases, and introduce therapeutic approaches targeting misfolding and aggregation of the expanded polyQ proteins, which are not only effective on a wide spectrum of polyQ diseases, but also broadly correct the functional abnormalities of multiple downstream cellular processes affected in the aggregation process of polyQ proteins. We hope that in the near future, effective therapies are developed, to bring hope to many patients suffering from currently intractable polyQ diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci7100128

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Proposed aggregation cascade of the expanded polyglutamine (polyQ) proteins and potential therapeutic targets for polyQ diseases.
Figure 1 Proposed aggregation cascade of the expanded polyglutamine (polyQ) proteins and potential therapeutic targets for polyQ diseases.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 147 references

Cited by

See all 71

Metadata

Authors
Takeuchi, T., & Nagai, Y.
Affiliations
The University of Osaka (JP)
Corresponding author
  • Takeuchi, Toshihide
  • Nagai, Yoshitaka
Venue
Brain Sciences
Publisher
MDPI AG
Published
2017-10-11
Volume
7
Issue
10
Pages
128
ISSN
2076-3425 (ISSN-L)
OpenAlex
W2762018403
Cited by
71
References
149
Citations by year
2026: 7 · 2025: 7 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 12 · 2020: 10 · 2019: 9 · 2018: 6
FWCI
0.84
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science
  • Ministry of Health, Labour and Welfare
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency
  • National Center of Neurology and Psychiatry
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
polyglutamine diseases, protein misfolding, protein aggregation, Huntington's disease, spinocerebellar ataxia, neurodegeneration, disease-modifying therapy, molecular pathogenesis, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases. https://app.cochat.ai/papers/10.3390/brainsci7100128
The paper
Takeuchi, T., & Nagai, Y. (2017). Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases. Brain Sciences. https://doi.org/10.3390/brainsci7100128

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.